Press Releases

August 19, 2024

New Findings by Friends of Cancer Research RWE Portfolio Published in JCI Clinical Cancer Informatics

New findings by Friends of Cancer Research (Friends) were published recently in JCO Clinical Cancer Informatics “Evaluation of real-world tumor response derived from electronic health record data sources: A feasibility analysis in mNSCLC patients treated with chemotherapy.” This salient publication demonstrates the feasibility of aligning disparate real-world (rw) data sources to evaluate rw-response to treatment…

July 18, 2024

NIH Director Monica Bertagnolli and Congressman Brett Guthrie to Receive the 2024 Cancer Leadership Awards

Friends of Cancer Research (Friends) is proud to announce our 2024 Cancer Leadership Award recipients: Director of the National Institutes of Health, Dr. Monica Bertagnolli, and U.S. Representative for Kentucky’s 2nd congressional district, the Honorable Brett Guthrie. These two extraordinary leaders will be honored on September 19, 2024, in Washington, DC. Dr. Monica Bertagnolli will…

June 17, 2024

New Publication: An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials

A new publication by Friends of Cancer Research (Friends) was published in Clinical Cancer Research, a journal of the American Association for Cancer Research, “An evaluation of novel oncology approvals with a PMR/C for assessing data in racial and ethnic populations underrepresented in premarket clinical trials.” This important publication used publicly available data to…

May 7, 2024

New Manuscript Provides Evidence and Key Considerations for the Use of ctDNA in Oncology

Washington, DC – May 7, 2024 – A new publication by Friends of Cancer Research (Friends) was recently published in the journal Diagnostics: “Advancing Evidence Generation for ctDNA: Lessons Learned from A Multi-Assay Study of Baseline ctDNA Levels Across Cancer Types and Stages.” This collaborative publication evaluates circulating tumor DNA (ctDNA) levels prior to cancer…

April 10, 2024

New Publication Outlines a Framework to Support More Efficient Clinical Development Programs

A new publication by Friends of Cancer Research (Friends) was published in Cytotherapy, “Accelerated Development of Genetically Engineered Cellular Therapies: A Framework for Extrapolating Data Across Related Products.” This exciting manuscript examines the current opportunities and challenges with development approaches of genetically engineered cellular therapies to propose solutions to optimize development. The publication outlines a…

February 1, 2024

Friends of Cancer Research Launches New Digital PATH Research Partnership

Friends of Cancer Research (Friends) is excited to announce the launch of a new research partnership, Digital and Computational Pathology Tool Harmonization (Digital PATH) Project. This project will identify factors that may contribute to variability in biomarker assessment across computational pathology platforms, propose areas for alignment in the field, and provide insights for shaping regulatory…

January 8, 2024

Friends of Cancer Research Announces Election of Dr. Roy Herbst to Board of Directors

Friends of Cancer Research (Friends) is honored to announce the addition of Roy S. Herbst, MD, PhD, Deputy Director of Yale Cancer Center and Smilow Cancer Hospital and Assistant Dean for Translational Research at Yale School of Medicine, to its Board of Directors. Dr. Herbst is a nationally recognized expert in lung cancer treatment and…

December 12, 2023

Friends of Cancer Research New Manuscript Shows Oncology Drugs Require Additional Dose Optimization After Approval

A new manuscript by Friends of Cancer Research (Friends) published today in AACR’s Clinical Cancer Research, shows that a substantial number of oncology drugs undergo additional dose evaluation after approval through Postmarketing Requirements (PMRs), studies that sponsors are required to conduct after approval to gather additional information about a product’s safety and/or efficacy. These findings…

November 17, 2023

Friends Statement on W. Kimryn Rathmell’s Nomination by President Biden as Director of the National Cancer Institute

Friends of Cancer Research (Friends) applauds President Biden for nominating Dr. W. Kimryn Rathmell as Director of the National Cancer Institute (NCI) and extends our deepest gratitude to recently confirmed Director of the National Institutes of Health, Dr. Monica Bertagnolli, for her steadfast leadership as Director of the NCI. “Dr. Rathmell brings extensive scientific expertise…

August 15, 2023

27th Cancer Leadership Awards Recipients Announced

FDA Commissioner Califf to Receive the Ellen V. Sigal Advocacy Leadership Award Congresswoman Dingell to Receive the Marlene A. Malek Public Service Award Washington, DC – August 15, 2023 – Friends of Cancer Research (Friends) is proud to announce our 2023 Cancer Leadership Awards honorees: Commissioner of the U.S. Food and Drug Administration, Dr. Robert Califf,…

Most read